The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers

Oncolytic Viruses in Cancer Treatment

(2017) Sean E. Lawler et al.   JAMA Oncology

Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma Cells

(2016) Mee Y. Bartee et al.   Clinical Lymphoma Myeloma & Leukemia

Virotherapy of digestive tumors with rodentparvovirus: overview and perspectives

(2016) Cherif Akladios et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Gene and virotherapy for hematological malignancies

(2016) Evidio Domingo-Musibay et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1

(2016) Rafael Josupeit et al.   Viruses-Basel

ALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway

(2016) Jinqiong Jiang et al.   OncoTargets and Therapy

Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice

(2016) Eric Bartee et al.   Molecular Therapy-Oncolytics

How I treat T-cell acute lymphoblastic leukemia in adults

(2015) M. R. Litzow et al.   BLOOD

Histone Deacetylase Inhibitors for Cutaneous T-Cell Lymphoma

(2015) Madeleine Duvic   DERMATOLOGIC CLINICS

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

(2015) Robert H.I. Andtbacka et al.   JOURNAL OF CLINICAL ONCOLOGY

Double-faceted mechanism of parvoviral oncosuppression

(2015) Karsten Geletneky et al.   Current Opinion in Virology

Viruses for Tumor Therapy

(2014) John Bell et al.   Cell Host & Microbe

Complementary Induction of Immunogenic Cell Death by Oncolytic Parvovirus H-1PV and Gemcitabine in Pancreatic Cancer

(2014) A. L. Angelova et al.   JOURNAL OF VIROLOGY

Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy

(2014) Stephen J. Russell et al.   MAYO CLINIC PROCEEDINGS

Viral Carcinogenesis: Factors Inducing DNA Damage and Virus Integration

(2014) Yan Chen et al.   Cancers

Reovirus modulates autophagy during oncolysis of multiple myeloma

(2013) Chandini M. Thirukkumaran et al.   Autophagy

Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity

(2013) A. Castleton et al.   BLOOD

Targeted therapy with monoclonal antibodies in acute lymphoblastic leukemia

(2013) Dieter Hoelzer   CURRENT OPINION IN ONCOLOGY

Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas

(2013) Junwei Li et al.   EMBO Molecular Medicine

Measles Virus Entry Through the Signaling Lymphocyte Activation Molecule Governs Efficacy of Mantle Cell Lymphoma Radiovirotherapy

(2013) Tanner S Miest et al.   MOLECULAR THERAPY

New viruses for cancer therapy: meeting clinical needs

(2013) Tanner S. Miest et al.   NATURE REVIEWS MICROBIOLOGY

Influence of the oncolytic parvovirus H-1, CTLA-4 antibody tremelimumab and cytostatic drugs on the human immune system in a human in vitro model of colorectal cancer cells

(2013) Bernd Heinrich et al.   OncoTargets and Therapy

Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol

(2012) Karsten Geletneky et al.   BMC CANCER

Epidemiology: clues to the pathogenesis of Burkitt lymphoma

(2012) Ian Magrath   BRITISH JOURNAL OF HAEMATOLOGY

Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β

(2012) S Naik et al.   CANCER GENE THERAPY

Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma

(2012) C. M. Thirukkumaran et al.   CLINICAL CANCER RESEARCH

HDAC inhibitors for the treatment of cutaneous T-cell lymphomas

(2012) Sophia Rangwala et al.   Future Medicinal Chemistry

Oncolytic virotherapy

(2012) Stephen J Russell et al.   NATURE BIOTECHNOLOGY

Human viruses: discovery and emergence

(2012) M. Woolhouse et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Pancreatic Cancer Surgery in the New Millennium

(2011) Werner Hartwig et al.   ANNALS OF SURGERY

Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent

(2011) Svitlana P. Grekova et al.   CANCER BIOLOGY & THERAPY

Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer

(2011) Svitlana P. Grekova et al.   CANCER BIOLOGY & THERAPY

Regression of Glioma in Rat Models by Intranasal Application of Parvovirus H-1

(2011) Irina Kiprianova et al.   CLINICAL CANCER RESEARCH

TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells

(2011) B A Cardoso et al.   LEUKEMIA

Differential Cytopathology and Kinetics of Measles Oncolysis in Two Primary B-cell Malignancies Provides Mechanistic Insights

(2011) Bella Patel et al.   MOLECULAR THERAPY

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

(2011) J. L. Clarke  et al.   NEURO-ONCOLOGY

Oncolytic parvoviruses as cancer therapeutics

(2010) Jean Rommelaere et al.   CYTOKINE & GROWTH FACTOR REVIEWS

CD20-targeted measles virus shows high oncolytic specificity in clinical samples from lymphoma patients independent of prior rituximab therapy

(2010) K-C Yaiw et al.   GENE THERAPY

Enhancement of NK cell antitumor responses using an oncolytic parvovirus

(2010) Rauf Bhat et al.   INTERNATIONAL JOURNAL OF CANCER

Improved Killing of Human High-Grade Glioma Cells by Combining Ionizing Radiation with Oncolytic Parvovirus H-1 Infection

(2010) Karsten Geletneky et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models

(2010) K. Geletneky et al.   NEURO-ONCOLOGY

Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV

(2009) A. L. Angelova et al.   CLINICAL CANCER RESEARCH

Infection and Killing of Multiple Myeloma by Adenoviruses

(2009) Julien S. Senac et al.   HUMAN GENE THERAPY

SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H-1PV

(2009) Sebastian Dempe et al.   INTERNATIONAL JOURNAL OF CANCER

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

(2009) Richard L. Piekarz et al.   JOURNAL OF CLINICAL ONCOLOGY

Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells

(2009) M Kim et al.   LEUKEMIA

Transcription factors down-stream of Ras as molecular indicators for targeting malignancies with oncolytic herpes virus

(2009) Tuba Esfandyari et al.   Molecular Oncology

Oncolytic Rat Parvovirus H-1PV, a Candidate for the Treatment of Human Lymphoma: In Vitro and In Vivo Studies

(2009) Assia L Angelova et al.   MOLECULAR THERAPY

Targeting the Apoptotic Pathway with BCL-2 Inhibitors Sensitizes Primary Chronic Lymphocytic Leukemia Cells to Vesicular Stomatitis Virus-Induced Oncolysis

(2008) V. F. Tumilasci et al.   JOURNAL OF VIROLOGY

Oncolytic virotherapy for multiple myeloma using a tumour-specific double-deleted vaccinia virus

(2008) H Deng et al.   LEUKEMIA

Primary cutaneous lymphomas: A population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003

(2008) Marie Odile Riou-Gotta et al.   LEUKEMIA & LYMPHOMA

Viruses associated with human cancer

(2007) Margaret E. McLaughlin-Drubin et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE